An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously

Cancer Gene Therapy, Published online: 15 December 2023; doi:10.1038/s41417-023-00712-0An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
Source: Cancer Gene Therapy - Category: Cancer & Oncology Authors: Source Type: research